Works matching IS 09509232 AND DT 2012 AND VI 31 AND IP 15

Results: 10

Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1923, doi. 10.1038/onc.2011.379

By:

Fernandez-L, A;
Squatrito, M;
Northcott, P;
Awan, A;
Holland, E C;
Taylor, M D;
Nahlé, Z;
Kenney, A M

Publication type:

Article

Regulation of APC/C<sup>Cdc20</sup> activity by RASSF1A-APC/C<sup>Cdc20</sup> circuitry.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1975, doi. 10.1038/onc.2011.372

By:

Chow, C;
Wong, N;
Pagano, M;
Lun, S W-M;
Nakayama, K-I;
Nakayama, K;
Lo, K-W

Publication type:

Article

Molecular mechanisms of cisplatin resistance.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1869, doi. 10.1038/onc.2011.384

By:

Galluzzi, L;
Senovilla, L;
Vitale, I;
Michels, J;
Martins, I;
Kepp, O;
Castedo, M;
Kroemer, G

Publication type:

Article

AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1949, doi. 10.1038/onc.2011.394

By:

Astle, M V;
Hannan, K M;
Ng, P Y;
Lee, R S;
George, A J;
Hsu, A K;
Haupt, Y;
Hannan, R D;
Pearson, R B

Publication type:

Article

Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1896, doi. 10.1038/onc.2011.378

By:

Paranjape, A N;
Mandal, T;
Mukherjee, G;
Kumar, M V;
Sengupta, K;
Rangarajan, A

Publication type:

Article

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1884, doi. 10.1038/onc.2011.380

By:

Papagiannakopoulos, T;
Friedmann-Morvinski, D;
Neveu, P;
Dugas, J C;
Gill, R M;
Huillard, E;
Liu, C;
Zong, H;
Rowitch, D H;
Barres, B A;
Verma, I M;
Kosik, K S

Publication type:

Article

Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1988, doi. 10.1038/onc.2011.387

By:

Taniguchi, H;
Jacinto, F V;
Villanueva, A;
Fernandez, A F;
Yamamoto, H;
Carmona, F J;
Puertas, S;
Marquez, V E;
Shinomura, Y;
Imai, K;
Esteller, M

Publication type:

Article

Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivin.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1938, doi. 10.1038/onc.2011.377

By:

Berezov, A;
Cai, Z;
Freudenberg, J A;
Zhang, H;
Cheng, X;
Thompson, T;
Murali, R;
Greene, M I;
Wang, Q

Publication type:

Article

Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1963, doi. 10.1038/onc.2011.373

By:

Kurasawa, Y;
Kozaki, K;
Pimkhaokham, A;
Muramatsu, T;
Ono, H;
Ishihara, T;
Uzawa, N;
Imoto, I;
Amagasa, T;
Inazawa, J

Publication type:

Article

MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.

Published in:

Oncogene, 2012, v. 31, n. 15, p. 1910, doi. 10.1038/onc.2011.381

By:

Geraldo, M V;
Yamashita, A S;
Kimura, E T

Publication type:

Article